If expenditure goes @ 4m per quarter into the future with 16-17m on hand, won't be long before more $ are required unless an upfront materialises. Not a good look for a little Aussie battler with 5 orphan indications. Perhaps in this cat eats dog world circling sharks can toy with their prey - figures.]
Agree. That wouldn’t be a good look.
So, unless they are pretty confident of a cash injection coming this quarter, wouldn’t it be prudent to stick with another quarter of modest R &D expenditure?
Hence, my interpretation that they’re fairly confident of a cash injection this quarter.
But perhaps that's just my wishful thinking...
NEU Price at posting:
$2.48 Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)